Bismuth complexes inhibit the SARS coronavirus
Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal › peer-review
Author(s)
Detail(s)
Original language | English |
---|---|
Pages (from-to) | 6464-6468 |
Journal / Publication | Angewandte Chemie - International Edition |
Volume | 46 |
Issue number | 34 |
Publication status | Published - 2007 |
Externally published | Yes |
Link(s)
Abstract
Hold tight: Bismuth complexes including ranitidine bismuth citrate effectively inhibit the nucleoside triphosphate hydrolase and DNA unwinding activities of the SARS coronavirus (SCV) helicase and dramatically reduce SCV replication levels in infected cells. This suggests that bismuth-based drugs should be further evaluated for the treatment of SCV infections in vivo. ss = single-stranded DNA, ds = duplex DNA. (Figure Presented). © 2007 Wiley-VCH Verlag GmbH & Co. KGaA.
Research Area(s)
- Antiviral agents, Bismuth, Enzymes, Helical structures, SARS coronavirus
Citation Format(s)
Bismuth complexes inhibit the SARS coronavirus. / Yang, Nan; Tanner, Julian A.; Zheng, Bo-Jian et al.
In: Angewandte Chemie - International Edition, Vol. 46, No. 34, 2007, p. 6464-6468.Research output: Journal Publications and Reviews (RGC: 21, 22, 62) › 21_Publication in refereed journal › peer-review